|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Depreciation | |||||
| Amortization of intangible assets | |||||
| Total depreciation and amortization | |||||
| Impairment of intangible asset | |||||
| Amortization of right-of-use lease assets | |||||
| Amortization of debt issuance costs | |||||
| Deferred income tax benefit | |||||
| Loss on disposal of fixed assets | |||||
| Stock-based compensation | |||||
| Unrealized foreign currency (gains) losses | |||||
| Amortization of premium accretion of discount on short-term investments | |||||
| Other liabilities | |||||
| Allowance for doubtful accounts | |||||
| Acquired in-process R&D acquired through the issuance of common stock | |||||
| Loss on capped call transaction | |||||
| Inducement expense related to exchange of convertible senior notes | |||||
| Inventory write-down | |||||
| Provision for excess and obsolete inventory | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable and accrued liabilities | |||||
| Deposits and other assets | |||||
| Net cash used in operating activities | |||||
| Investing activities | |||||
| Cash paid for acquisitions, net of cash acquired | |||||
| Purchase of certain real property | |||||
| Purchases of property and equipment | |||||
| Purchases of short-term investments | |||||
| Proceeds from sales and maturities of short-term investments | |||||
| Proceeds from disposal of property and equipment | |||||
| Investment in company-owned life insurance | |||||
| Other investing activities | |||||
| Net cash (used in) provided by investing activities | |||||
| Financing activities | |||||
| Proceeds from partial unwinding of capped calls related to issuance of convertible senior notes | |||||
| Proceeds from exercise of stock options | |||||
| Share purchases under Employee Stock Purchase Plan | |||||
| Payments of employee taxes related to vested restricted stock units | |||||
| Payments related to convertible senior notes | |||||
| Payments related to capped call transactions | |||||
| Principal paid on finance lease | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net (decrease) increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental schedule of noncash investing and financing activities | |||||
| Purchases of property and equipment included in accounts payable and accrued liabilities | |||||
| Contingent consideration acquired | |||||
| Convertible senior notes exchanged for common stock, net of debt issuance costs | |||||
| Issuance of common stock related to conversion of convertible senior notes, net of debt issuance costs | |||||
| Supplemental disclosures of cash flow information | |||||
| Taxes paid, net of refunds | |||||
| Interest paid on convertible senior notes | |||||
| Other interest paid | |||||
Loading...